These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 1622114

  • 1. Antiestrogenic effects of Z-1, 1-dichloro-2,3 diphenyl-2-(4-methoxyphenyl)cyclopropane(5a) on human breast cancer cells in culture.
    Jain PT, Pento JT, Magarian RA.
    Anticancer Res; 1992; 12(3):585-90. PubMed ID: 1622114
    [Abstract] [Full Text] [Related]

  • 2. Antitumor mechanism of action of a cyclopropyl antiestrogen (compound 7b) on human breast cancer cells in culture.
    Jain PT, Pento JT, Magarian RA.
    Cancer Chemother Pharmacol; 1996; 38(3):238-44. PubMed ID: 8646798
    [Abstract] [Full Text] [Related]

  • 3. The influence of a novel cyclopropyl antiestrogen (compound 7a) on human breast cancer cells in culture.
    Jain PT, Pento JT, Magarian RA.
    Breast Cancer Res Treat; 1993; 25(3):225-33. PubMed ID: 8369524
    [Abstract] [Full Text] [Related]

  • 4. Concentration-dependent mitogenic and antiproliferative actions of 2-methoxyestradiol in estrogen receptor-positive human breast cancer cells.
    Liu ZJ, Zhu BT.
    J Steroid Biochem Mol Biol; 2004 Mar; 88(3):265-75. PubMed ID: 15120420
    [Abstract] [Full Text] [Related]

  • 5. Structure-activity relationships of nonisomerizable derivatives of tamoxifen: importance of hydroxyl group and side chain positioning for biological activity.
    Murphy CS, Parker CJ, McCague R, Jordan VC.
    Mol Pharmacol; 1991 Mar; 39(3):421-8. PubMed ID: 2005879
    [Abstract] [Full Text] [Related]

  • 6. Differential sensitivity of human breast cancer cell lines to the growth-inhibitory effects of tamoxifen.
    Reddel RR, Murphy LC, Hall RE, Sutherland RL.
    Cancer Res; 1985 Apr; 45(4):1525-31. PubMed ID: 3978620
    [Abstract] [Full Text] [Related]

  • 7. Cytostatic and cytotoxic action of Z-1, 1-dichloro-2,3-diphenylcyclopropane in three human breast cancer cell lines.
    ter Haar E, Day BW.
    Anticancer Res; 1996 Apr; 16(3A):1107-15. PubMed ID: 8702221
    [Abstract] [Full Text] [Related]

  • 8. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
    Swami S, Krishnan AV, Feldman D.
    Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
    [Abstract] [Full Text] [Related]

  • 9. Non-steroid receptor-mediated antiproliferative activity of styrylpyrone derivative in human breast cancer cell lines.
    Pihie AH, Stanslas J, Din LB.
    Anticancer Res; 1998 Aug; 18(3A):1739-43. PubMed ID: 9673398
    [Abstract] [Full Text] [Related]

  • 10. Influence of cyclopropyl antiestrogens on the cell cycle kinetics of MCF-7 human breast cancer cells.
    Jain PT, Pento JT, Magarian RA.
    Anticancer Res; 1995 Aug; 15(6B):2529-32. PubMed ID: 8669818
    [Abstract] [Full Text] [Related]

  • 11. [Cytotoxicity of tamoxifen and its principal metabolites in human breast cancer cell lines].
    Bachmann-Moisson N, Barberi-Heyob M, Merlin JL, Ledrich ML, Batt AM, Guillemin F.
    Bull Cancer; 1996 Oct; 83(10):808-15. PubMed ID: 8952630
    [Abstract] [Full Text] [Related]

  • 12. A comparison of the antitumor activity of two triarylcyclopropyl antiestrogens (compounds 4d and 5c) on human breast cancer cells in culture.
    Jain PT, Pento JT, Magarian RA.
    Anticancer Drugs; 1994 Aug; 5(4):429-36. PubMed ID: 7949247
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and biological evaluation of basic side chain derivatives of Analog II as pure antiestrogens and antitumor agents.
    Magarian RA, Avor KS, Overacre LB, Kunchandy J, Paxton TR.
    Anticancer Drug Des; 1995 Jun; 10(4):311-31. PubMed ID: 7786397
    [Abstract] [Full Text] [Related]

  • 14. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H, Ancelin M, Lardeux B, Milanini J, Perrot-Applanat M.
    Cancer Res; 2002 Sep 01; 62(17):4977-84. PubMed ID: 12208749
    [Abstract] [Full Text] [Related]

  • 15. Antiestrogenic potency and binding characteristics of the triphenylethylene H1285 in MCF-7 human breast cancer cells.
    Sheen YY, Ruh TS, Mangel WF, Katzenellenbogen BS.
    Cancer Res; 1985 Sep 01; 45(9):4192-9. PubMed ID: 4040807
    [Abstract] [Full Text] [Related]

  • 16. The effect of droloxifene on the insulin-like growth factor-I-stimulated growth of breast cancer cells.
    Kawamura I, Lacey E, Mizota T, Tsujimoto S, Nishigaki F, Manda T, Shimomura K.
    Anticancer Res; 1994 Sep 01; 14(2A):427-31. PubMed ID: 8017842
    [Abstract] [Full Text] [Related]

  • 17. Cellular targets of the anti-breast cancer agent Z-1,1-dichloro-2,3-diphenylcyclopropane: type II estrogen binding sites and tubulin.
    ter Haar E, Hamel E, Balachandran R, Day BW.
    Anticancer Res; 1997 Sep 01; 17(3C):1861-9. PubMed ID: 9216636
    [Abstract] [Full Text] [Related]

  • 18. Effects of pharmacological concentrations of estrogens on proliferation and cell cycle kinetics of human breast cancer cell lines in vitro.
    Reddel RR, Sutherland RL.
    Cancer Res; 1987 Oct 15; 47(20):5323-9. PubMed ID: 3652038
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of colon and breast carcinoma cell growth by interleukin-4.
    Toi M, Bicknell R, Harris AL.
    Cancer Res; 1992 Jan 15; 52(2):275-9. PubMed ID: 1728401
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of human breast cancer cell proliferation in tissue culture by the neuroleptic agents pimozide and thioridazine.
    Strobl JS, Kirkwood KL, Lantz TK, Lewine MA, Peterson VA, Worley JF.
    Cancer Res; 1990 Sep 01; 50(17):5399-405. PubMed ID: 2386945
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.